Literature DB >> 23988856

A consecutive and prospective stroke database covers the state of Baden-Wuerttemberg with 10.8 million inhabitants in Germany.

C Gumbinger1, B Reuter, H Wiethölter, I Bruder, S Rode, E Drewitz, W Habscheid, M Daffertshofer, C Diehm, S Neumaier, R Kern, P A Ringleb, W Hacke, M G Hennerici.   

Abstract

BACKGROUND: In 1998 Baden-Wuerttemberg (BW), a federal state in southwest Germany with 10.8 million inhabitants, implemented a structured medical concept for the treatment of acute stroke.
METHODS: Since 2004 participation in the BW stroke database is mandatory for all hospitals in BW involved in acute stroke care. The stroke database includes all inpatients ≥18 years of age who have suffered an ischemic or hemorrhagic stroke within 7 days before hospitalization. This article presents methodological aspects and first results of the BW stroke database in the time period from 2007 to 2011.
RESULTS: Annual inclusion numbers increased continuously (29,422 vs. 35,724, p < 0.001). Median age of stroke onset was stable over time. The proportion of stroke patients ≥80 years increased from 36.9 to 38.8% (p < 0.001). Rates of patients treated in neurology departments rose from 50.7 to 60.9% (p < 0.001) and numbers of patients treated in stroke units rose from 59.1 to 68.4% (p < 0.001). Admission via emergency medical systems increased from 42.8 to 49.7% (p < 0.001) and arrival within 3 h increased from 29.8 to 34.4% (p < 0.001).
CONCLUSION: We present results from a large, prospective and consecutive stroke patient database. This first analysis demonstrates a continuous increase of absolute and relative numbers of stroke patients who arrive within 3 h after onset, are hospitalized in neurology departments and treated in stroke units, and are aged ≥80 years.
Copyright © 2013 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2013        PMID: 23988856     DOI: 10.1159/000354356

Source DB:  PubMed          Journal:  Neuroepidemiology        ISSN: 0251-5350            Impact factor:   3.282


  8 in total

Review 1.  [Juvenile stroke - what is important?]

Authors:  M Fischer; B Eckert; J Röther
Journal:  Nervenarzt       Date:  2018-02       Impact factor: 1.214

2.  Impact of bridging thrombolysis on clinical outcome in stroke patients undergoing endovascular thrombectomy: a retrospective analysis of a regional stroke registry.

Authors:  Fatih Seker; Susanne Bonekamp; Susanne Rode; Sonja Hyrenbach; Martin Bendszus; Markus A Möhlenbruch
Journal:  Neuroradiology       Date:  2020-12-16       Impact factor: 2.804

3.  High total hospitalization cost but low cost of imaging studies in recurrent acute ischemic stroke patients.

Authors:  Young Dae Kwon; Sung Sang Yoon; Hyejung Chang
Journal:  PLoS One       Date:  2014-07-21       Impact factor: 3.240

4.  Access, timing and frequency of very early stroke rehabilitation - insights from the Baden-Wuerttemberg stroke registry.

Authors:  Björn Reuter; Christoph Gumbinger; Tamara Sauer; Horst Wiethölter; Ingo Bruder; Curt Diehm; Peter A Ringleb; Werner Hacke; Michael G Hennerici; Rolf Kern
Journal:  BMC Neurol       Date:  2016-11-16       Impact factor: 2.474

5.  Diurnal Variation of Intravenous Thrombolysis Rates for Acute Ischemic Stroke and Associated Quality Performance Parameters.

Authors:  Björn Reuter; Tamara Sauer; Christoph Gumbinger; Ingo Bruder; Stella Preussler; Werner Hacke; Michael G Hennerici; Peter A Ringleb; Rolf Kern; Christian Stock
Journal:  Front Neurol       Date:  2017-07-21       Impact factor: 4.003

6.  MRI as a first-line imaging modality in acute ischemic stroke: a sustainable concept.

Authors:  Katharina Althaus; Jens Dreyhaupt; Sonja Hyrenbach; Elmar H Pinkhardt; Jan Kassubek; Albert C Ludolph
Journal:  Ther Adv Neurol Disord       Date:  2021-08-27       Impact factor: 6.570

7.  Intravenous Thrombolysis is Effective in Young Adults: Results from the Baden-Wuerttemberg Stroke Registry.

Authors:  Björn Reuter; Christoph Gumbinger; Tamara Sauer; Horst Wiethölter; Ingo Bruder; Curt Diehm; Peter A Ringleb; Rolf Kern; Werner Hacke; Michael G Hennerici
Journal:  Front Neurol       Date:  2015-11-04       Impact factor: 4.003

8.  Time to treatment with recombinant tissue plasminogen activator and outcome of stroke in clinical practice: retrospective analysis of hospital quality assurance data with comparison with results from randomised clinical trials.

Authors:  Christoph Gumbinger; Björn Reuter; Christian Stock; Tamara Sauer; Horst Wiethölter; Ingo Bruder; Susanne Rode; Rolf Kern; Peter Ringleb; Michael G Hennerici; Werner Hacke
Journal:  BMJ       Date:  2014-05-30
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.